Drug Development Consulting

Strategic consulting at every stage of a product’s lifecycle

Encorium offers Drug Development and Regulatory Consulting at every stage of a product’s lifecycle, from due diligence through all clinical development phases and into the peri/post-approval period. We provide program/study design and oversight support for pre-clinical as well as Phase I through Phase IV clinical trials. Our feasibility assessments and detailed budgetary modeling help define an optimal balance between the number of study sites, patient recruitment rate and geographic scope of the program and cost.

Encorium is experienced in providing clients involved in the Research and Development of medicinal products with advice and support services in the planning of their development programs. This may cover preparation and/or review of documentation on e.g. quality (drug substance and drug product) and nonclinical and clinical documentation. Furthermore, through regulatory consultancy we aim to achieve optimal timelines for clinical trial authorisation and approval. Encorium is also experienced in the organization of scientific advice consultation with competent authorities (e.g. EMEA, national authorities in EU).

These services are of relevance to companies within the EU who wish to broaden the fund of development experience contributing to their programs, and also to non-EU companies who wish to retain local experience when placing development work in Europe.

Contact Us

For enquiries on Encorium's services and capabilities, please contact info@encorium.com alternatively contact your local Encorium operations (see the site location map).

Encorium Headquarter

Encorium Oy
Keilaranta 10
FI-02150 Espoo
Finland
Tel: +358 20 751 8200
Fax:
Clinical Department
+358 20 751 8250
Administration
+358 20 751 8255
info@encorium.com